MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.41
-0.01 (-0.70%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,070.2% upside
Low Target
$21.05
Average Target
$30.60
High Target
$40.98
Current Price
$1.41
Current
$1.41
$1.41
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Scenario Analysis
Bear Case
$21.05
1,392.9%
Low target
Base Case
$30.60
+2,070.2%
Avg target
Bull Case
$40.98
+2,806.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.95
-64.3% from high
52-Week Low
$1.25
+12.8% from low
Target vs 52W High
$30.60
+674.7% vs high
Next Earnings Report
May 19, 2026
1d
tomorrow
EPS Est: $-0.53
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |